Professor Barry Furr, a non-executive director at the animal breeding technology group Genus, has spent £30,000 more than doubling his stake in the animal breeding company, the firm confirmed today.
He bought 5,000 shares at 600p a time and now has 8,000.
Furr, a former chief scientist for the drug giant AstraZeneca, bought his initial stake of 3,000 shares at 680p a time in October.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Genus sells breeding technology products to livestock and farmers.
Top Director Buys
Value: £61,350
Value: £30,000
Value: £24,880
Value: £14,880
Top Director Sells
Value: £410,000
-
What Disney tells us about how we draw investment conclusions -
High pension fees could take £70k from your retirement pot – time to check what you’re payingEight out of 10 savers have no idea what fees they are paying to their pension provider to manage their retirement fund, and these charges can vary wildly.
